CD8A and non-small cell lung carcinoma: To address the relevance of these findings for human, we re-analyzed scRNA-seq data of tumor-infiltrating CD8 T cells in clinical samples from non-small-cell lung cancer (NSCLC) patients after treatment with anti-PD155.